Thoratec Hopes MCAC Will Follow Blues’ Lead To Cover Destination LVADs

Thoratec expects to meet with the Medicare Coverage Advisory Committee in early March to discuss expanding coverage of the HeartMate SNAP-VE left-ventricular assist device to include destination therapy for end-stage heart failure patients

More from Archive

More from Medtech Insight